Finance

Lists
AIDX:NASDAQ
20/20 Biolabs Inc
0,46 US$
+0,73%
(+0,0033) 1D
0,45 US$
-1,14% (-0,0052)
Pre-market
Closed: 7 აგვ, 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AIDX...
Open
0,44 US$
High
0,47 US$
Low
0,43 US$
Mkt. cap
5,60 მლნ.
Avg. vol.
209,94 ათ.
Volume
30,53 ათ.
52-wk high
50,00 US$
52-wk low
0,40 US$
EPS
-0,94 US$
No. of employees
9
Open
0,44 US$
High
0,47 US$
Low
0,43 US$
Mkt. cap
5,60 მლნ.
Avg. vol.
209,94 ათ.
Volume
30,53 ათ.
52-wk high
50,00 US$
52-wk low
0,40 US$
EPS
-0,94 US$
No. of employees
9
About 20/20 Biolabs Inc
CEO-
Employees9
Founded2000
Headquartersროკვილი, მერილენდი, ამერიკის შეერთებული შტატები
SectorMedical device
Website2020biolabs.com
Analyst ratings
Based on 1 analyst giving stock ratings to AIDX in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for AIDX in the last 3 months
Highest
Current 0,46 US$
5,00 US$ (+998,42%)
Average
5,00 US$ (+998,42%)
Lowest
5,00 US$ (+998,42%)
Analyst
Recommendation
Action
Price target
Projected
Date
Michael Okunewitch
Maxim Group
Buy
Maintained
5,00 US$
+998,4%
05/21/2026
Brian Kinstlinger
Alliance Global Partners
Buy
Maintained
2,00 CA$
+339,4%
05/08/2026
Justin Keywood
Stifel Nicolaus
Buy
Maintained
2,50 CA$
+449,2%
03/20/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
მარ. 2025
სექ. 2025
დეკ. 2025
მარ. 2026
Revenue
553,82 ათ.
417,98 ათ.
538,27 ათ.
353,38 ათ.
Cost of goods sold
388,02 ათ.
272,91 ათ.
407,86 ათ.
290,49 ათ.
Cost of revenue
388,02 ათ.
272,91 ათ.
407,86 ათ.
290,49 ათ.
Research and development expenses
136,83 ათ.
131,06 ათ.
130,55 ათ.
153,48 ათ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
801,14 ათ.
814,18 ათ.
912,71 ათ.
1,35 მლნ.
Operating expense
937,98 ათ.
945,24 ათ.
1,04 მლნ.
1,51 მლნ.
Total operating expenses
1,33 მლნ.
1,22 მლნ.
1,45 მლნ.
1,80 მლნ.
Operating income
-772,18 ათ.
-800,17 ათ.
-912,85 ათ.
-1,44 მლნ.
Other non operating income
-115,00
-
-273,03 ათ.
-471,12 ათ.
EBT including unusual items
-764,58 ათ.
-825,54 ათ.
-1,31 მლნ.
-2,17 მლნ.
EBT excluding unusual items
-764,58 ათ.
-825,54 ათ.
-1,31 მლნ.
-2,17 მლნ.
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-764,58 ათ.
-825,54 ათ.
-1,31 მლნ.
-2,17 მლნ.
Net profit margin
-138,06%
-197,51%
-242,96%
-615,45%
Earnings per share
-
-
-
-
Interest and investment income
8,46 ათ.
4,18 ათ.
3,09 ათ.
6,65 ათ.
Interest expense
-740,00
-29,55 ათ.
-124,98 ათ.
-267,01 ათ.
Net interest expenses
7,72 ათ.
-25,37 ათ.
-121,90 ათ.
-260,36 ათ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-748,73 ათ.
-779,11 ათ.
-892,71 ათ.
-1,43 მლნ.
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები